The inhibitory in-vitro effect of high-dose levosimendan on platelet function may be mediated through its action as a phosphodiesterase inhibitor

Saved in:
Bibliographic Details
Main Authors: Plaschke, Konstanze (Author) , Bent, Franziska (Author) , Rosenhagen, Claudia (Author) , Wagner, Sören (Author) , Hofer, Stefan (Author) , Kopitz, Jürgen (Author)
Format: Article (Journal)
Language:English
Published: May 2012
In: Coronary artery disease
Year: 2012, Volume: 23, Issue: 3, Pages: 215-220
ISSN:1473-5830
DOI:10.1097/MCA.0b013e32835167cc
Online Access:Verlag, Volltext: http://dx.doi.org/10.1097/MCA.0b013e32835167cc
Verlag, Volltext: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00019501-201205000-00012
Get full text
Author Notes:Konstanze Plaschke, Franziska Bent, Claudia Rosenhagen, Sören Wagner, Stefan Hofer, Jürgen Kopitz
Description
Item Description:Gesehen am 05.06.2018
Physical Description:Online Resource
ISSN:1473-5830
DOI:10.1097/MCA.0b013e32835167cc